RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to MAPK14

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
LOSMAPIMOD	Small molecule	Facioscapulohumeral dystrophy	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
ARRY-797	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
ARRY-797	Small molecule	ankylosing spondylitis	MAP kinase p38 alpha inhibitor	2.0	Terminated	ClinicalTrials
DORAMAPIMOD	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	2.0	Terminated	ClinicalTrials
PH-797804	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
TALMAPIMOD	Small molecule	multiple myeloma	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
FX-005	Small molecule	osteoarthritis, knee	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
TAK-715	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
RALIMETINIB	Small molecule	ovarian cancer	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
RALIMETINIB	Small molecule	primary peritoneal carcinoma	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	COVID-19	MAP kinase p38 alpha inhibitor	3.0	Terminated	ClinicalTrials
ARRY-797	Small molecule	osteoarthritis, knee	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
PEXMETINIB	Small molecule	myelodysplastic syndrome	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
PF-03715455	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	2.0	Terminated	ClinicalTrials
LOSMAPIMOD	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
NEFLAMAPIMOD	Small molecule	Dementia	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
RALIMETINIB	Small molecule	cancer	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
NEFLAMAPIMOD	Small molecule	Huntington disease	MAP kinase p38 alpha inhibitor	2.0	Terminated	ClinicalTrials
NEFLAMAPIMOD	Small molecule	Alzheimer disease	MAP kinase p38 alpha inhibitor	2.0	Recruiting	ClinicalTrials
PH-797804	Small molecule	postherpetic neuralgia	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	atherosclerosis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
ARRY-797	Small molecule	dilated cardiomyopathy	MAP kinase p38 alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
PH-797804	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	atherosclerosis	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
DORAMAPIMOD	Small molecule	psoriasis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	acute coronary syndrome	MAP kinase p38 alpha inhibitor	3.0	Completed	ClinicalTrials
SEMAPIMOD	Small molecule	Crohn's disease	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
PH-797804	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	focal segmental glomerulosclerosis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
NEFLAMAPIMOD	Small molecule	Alzheimer disease	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
RALIMETINIB	Small molecule	glioblastoma multiforme	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	cardiovascular disease	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
PF-03715455	Small molecule	asthma	MAP kinase p38 alpha inhibitor	2.0	Terminated	ClinicalTrials
DILMAPIMOD	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	major depressive disorder	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	Facioscapulohumeral dystrophy	MAP kinase p38 alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
BMS-582949	Small molecule	psoriasis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
PG-760564	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
TALMAPIMOD	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
GSK-610677	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	major depressive disorder	MAP kinase p38 alpha inhibitor	2.0	Terminated	ClinicalTrials
DILMAPIMOD	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
SEMAPIMOD	Small molecule	Crohn's disease	MAP kinase p38 alpha inhibitor	2.0	Terminated	ClinicalTrials
DILMAPIMOD	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
RALIMETINIB	Small molecule	fallopian tube cancer	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	acute coronary syndrome	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
ARRY-797	Small molecule	toothache	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
DILMAPIMOD	Small molecule	acute lung injury	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
AZD-7624	Small molecule	inflammation	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
PH-797804	Small molecule	osteoarthritis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
ACUMAPIMOD	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	Facioscapulohumeral dystrophy	MAP kinase p38 alpha inhibitor	3.0	Recruiting	ClinicalTrials
ARRY-797	Small molecule	dilated cardiomyopathy	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
PH-797804	Small molecule	pain	MAP kinase p38 alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DILMAPIMOD	Small molecule	neuropathic pain	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
AZD-7624	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
DILMAPIMOD	Small molecule	coronary artery disease	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
AZD-7624	Small molecule	asthma	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
TALMAPIMOD	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
LY-3007113	Small molecule	metastatic malignant neoplasm	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	neuropathic pain	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
AZD-7624	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
VX-702	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
KC-706	Small molecule	pemphigus vulgaris	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
PF-03715455	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials
RALIMETINIB	Small molecule	breast cancer	MAP kinase p38 alpha inhibitor	2.0	Terminated	ClinicalTrials
DILMAPIMOD	Small molecule	chronic obstructive pulmonary disease	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
BMS-582949	Small molecule	rheumatoid arthritis	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
NEFLAMAPIMOD	Small molecule	Cognitive impairment	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
BMS-582949	Small molecule	vascular disease	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	Disorder of lipid metabolism	MAP kinase p38 alpha inhibitor	2.0	Completed	ClinicalTrials
LOSMAPIMOD	Small molecule	acute coronary syndrome	MAP kinase p38 alpha inhibitor	1.0	Completed	ClinicalTrials

Welcome to

RBP World!

Drugs target to MAPK14

Targets details